AU584551B2 - The use of penicillamine for the treatment of immune deficiency diseases - Google Patents

The use of penicillamine for the treatment of immune deficiency diseases

Info

Publication number
AU584551B2
AU584551B2 AU58440/86A AU5844086A AU584551B2 AU 584551 B2 AU584551 B2 AU 584551B2 AU 58440/86 A AU58440/86 A AU 58440/86A AU 5844086 A AU5844086 A AU 5844086A AU 584551 B2 AU584551 B2 AU 584551B2
Authority
AU
Australia
Prior art keywords
penicillamine
immune deficiency
treatment
deficiency diseases
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU58440/86A
Other languages
English (en)
Other versions
AU5844086A (en
Inventor
Prakash Prof.Dr.phil.nat. Chandra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa GmbH filed Critical Degussa GmbH
Publication of AU5844086A publication Critical patent/AU5844086A/en
Application granted granted Critical
Publication of AU584551B2 publication Critical patent/AU584551B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU58440/86A 1985-06-08 1986-06-06 The use of penicillamine for the treatment of immune deficiency diseases Ceased AU584551B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3520624 1985-06-08
DE3520624 1985-06-08

Publications (2)

Publication Number Publication Date
AU5844086A AU5844086A (en) 1986-12-11
AU584551B2 true AU584551B2 (en) 1989-05-25

Family

ID=6272806

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58440/86A Ceased AU584551B2 (en) 1985-06-08 1986-06-06 The use of penicillamine for the treatment of immune deficiency diseases

Country Status (8)

Country Link
US (1) US4847297A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0204989B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS61286325A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE73995T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU584551B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1283859C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3684514D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA864263B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
MX9205549A (es) * 1991-09-30 1993-05-01 Jess G Thoene Metodo para el tratamiento de vih.
US6764693B1 (en) 1992-12-11 2004-07-20 Amaox, Ltd. Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants
US5725870A (en) * 1993-10-15 1998-03-10 Thoene; Jess G. Methods, composites and articles for contraception
EP0789565A4 (en) * 1993-10-15 1999-03-24 Jess G Thoene PREVENTION OF HIV INFECTION
US6117904A (en) * 1999-09-03 2000-09-12 Murphy; Donald M. Treatment of pruritus
US6541517B1 (en) * 1999-09-03 2003-04-01 Donald M. Murphy Treatment of skin disorders
US20070134277A1 (en) * 2005-12-09 2007-06-14 Children's Medical Center Corporation Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms
US20100166833A1 (en) * 2007-05-07 2010-07-01 Technion Research & Development Foundation Ltd. Compositions, articles and methods for preventing or reducing tobacco-associated damage
US20190282519A1 (en) * 2018-03-19 2019-09-19 Cronus Research Labs Private Limited Pencillamine oral composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1025176A (en) * 1974-07-19 1977-07-21 Battelle Memorial Institute Preparation of liposomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB585413A (en) * 1944-06-19 1947-02-06 Wellcome Found Improved method for the resolution of penicillamine
GB1424432A (en) * 1972-03-25 1976-02-11 Degussa Pharmaceutical compositions
US4487780A (en) * 1979-09-18 1984-12-11 Scheinberg Israel H Method of treatment of rheumatoid arthritis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1025176A (en) * 1974-07-19 1977-07-21 Battelle Memorial Institute Preparation of liposomes

Also Published As

Publication number Publication date
EP0204989A3 (en) 1989-12-20
DE3684514D1 (de) 1992-04-30
ZA864263B (en) 1987-02-25
EP0204989B1 (de) 1992-03-25
EP0204989A2 (de) 1986-12-17
US4847297A (en) 1989-07-11
CA1283859C (en) 1991-05-07
ATE73995T1 (de) 1992-04-15
JPS61286325A (ja) 1986-12-16
JPH0380772B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-12-26
AU5844086A (en) 1986-12-11

Similar Documents

Publication Publication Date Title
AU597635B2 (en) Treatment of diseases caused by retroviruses
NO875378L (no) Fremgangsmaate for fremstilling av granulocyttstimulerendefaktor (polypeptidderivater).
AU1256288A (en) Treatment of human viral infections by dsrna combined with viral inhibitors
AU4495093A (en) The use of the IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections
AU584551B2 (en) The use of penicillamine for the treatment of immune deficiency diseases
EP0458699A3 (en) Use of baclofen for the preparation of medicaments for the treatment of angina pectoris
AU6518890A (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO881190D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 9- (beta-d-deoxyribofuranosyl)-mucleosider.
NO881636D0 (no) Fremgangsmaate for fremstilling av fiberholdig soyamelk.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
DK450086A (da) 12- og 13-bromergolinderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse
NO865139L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperazin-1,4-naftalendion-derivater.
AU3186189A (en) Isolation of 24-R scymnol
AU586520B2 (en) Oligomericdiazaoxaspirodecanes, preparation thereof and use thereof as light stabilizers for polymers
AU7633987A (en) The use of 15-deoxyspergualine as a pharmaceutical
NO164972C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo-1,8-diamino-4-aza-octaner.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO884792L (no) Fremgangsmaate for fremstilling av alfa-olefinpolymer.
IT8723034A0 (it) Procedimento per la preparazione di componenti ceramici.
NO884635L (no) Fremgangsmaate for behandling av voerter.
NO169337C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme nafthalenderivater.
NO165399C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (5r,6s)-6-((r)-1-hydroksyetyl)-penem-derivater.
AU588493B2 (en) Treatment of diseases caused by viruses